from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1730c/-

LFCtreatmentdescriptionclass of inhibitor

-0.459

Amikacinug/mL Amikacintranslation

0.645

Cap5-10ug/mL Capreomycintranslation

-0.074

Rox10-50 ug/mL Roxithromycintranslation

0.442

SM2-5 ug/mL Streptomycintranslation

0.773

Tet5-10 ug/mL Tetracyclinetranslation

0.086

Rif0.2-5ug/mL Rifampicintranscription

0.048

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.052

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.427

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.270

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.056

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.077

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.000

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.526

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.000

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.517

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.328

Nigericin50 uM Nigericinrespiration

0.489

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

0.364

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.525

menadione6-10 ug/mL Menadionerespiration

-0.561

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.529

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.541

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-2.969

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.496

NRP_1Non-replicating persistence stage 1dosRassociated

0.113

Amp0.2mg/mL AmpicillincellWall

0.065

Cephalexin20-100 ug/mL CephalexincellWall

0.610

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.489

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.147

EMB10-20 ug/mL EthambutolcellWall

0.315

Eta12-40 ug/mL EthionamidecellWall

-0.817

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.105

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.109

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.144

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.060

BZA0.12 mg/mL BenzamidearomaticAmides

-0.020

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.034

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.449

H2O24 mM hydrogen peroxideDNAdamaging

-0.527

Levo10 ug/mL LevofloxacinDNAdamaging

0.279

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.979

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.401

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.634

UVUV-irradiationDNAdamaging

0.280

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.987

Antimycin12.5-50 ug/mL Antimycin A?

0.622

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.442

PA_110-50 ug/mL Antitubercular compound PA-1?

0.165

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.324

PA8240.2-2 ug/mL PA-824?

0.857

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

1.569

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.837

Verapamil50 uM Verapamil?

0.844

mercaptoethanol2 mM 2-Mercaptoethanol?

1.305

methoxatin10-20 ug/mL Methoxatin?